Watts Ryan J.

EDGAR CIK 0001724310

Denali Therapeutics Inc. - DNLI

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
CEO Director
President and CEO
Direct Buys
0
$0
0 Shares
Direct Sells
1
($580,767)
-35,198 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
01/06/2026
01/08/2026
Sell
-35,198 @ $16.50
 ($580,767) 296,833 (-10.60%) Direct